DANIEL BRADBURY - 24 Jan 2022 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Greg Acosta, Attorney-in-fact
Issuer symbol
CSTL
Transactions as of
24 Jan 2022
Net transactions value
-$518,281
Form type
4
Filing time
26 Jan 2022, 15:38:26 UTC
Previous filing
24 Jan 2022
Next filing
11 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Sale $240,587 -6,802 -3.1% $35.37 216,068 24 Jan 2022 By LLC F1, F2, F3
transaction CSTL Common Stock Sale $138,712 -3,914 -3.2% $35.44 117,537 24 Jan 2022 By Daniel Bradbury Irrecovable Descendant's Trust F1, F4, F5
transaction CSTL Common Stock Sale $138,982 -3,915 -3.2% $35.50 117,562 24 Jan 2022 By Annette Bradbury Irrecovable Descendant's Trust F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted collectively by BioBrit, LLC (the "LLC"), The Annette E. Bradbury Irrevocable Descendants' Trust, and The Daniel M. Bradbury Irrevocable Descendants' Trust on November 30, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $35.04 to $35.66, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4 This transaction was executed in multiple trades at prices ranging from $35.36 to $35.48, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F6 This transaction was executed in multiple trades at prices ranging from $35.36 to $35.60, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.